Quantum-Si to Present at H.C. Wainwright 27th Annual Global Investment Conference
ByAinvest
Wednesday, Aug 20, 2025 7:26 am ET1min read
QSI--
Key executives from Quantum-Si, including CEO Jeff Hawkins and Chief Financial Officer Jeff Keyes, will be present at the conference. Hawkins will lead a fireside chat on Tuesday, September 9, 2025, at 10:00 AM Eastern Time. Additionally, Keyes will be available for one-on-one meetings throughout the day on the same date. A live and archived webcast of the event will be accessible on the Quantum-Si website under the "Investors" section in the "Events & Presentations" category [1][2].
Quantum-Si is a proteomics technology company that specializes in single-molecule protein analysis. The company's benchtop platform enables real-time kinetic-based detection, allowing researchers to move beyond traditional, multistep workflows and access dynamic, functional protein insights with unparalleled resolution. This innovation simplifies and accelerates protein analysis, potentially enhancing various research and development efforts.
For more information about Quantum-Si Incorporated, visit their website at quantum-si.com or follow them on LinkedIn or X.
References:
[1] https://www.biospace.com/press-releases/quantum-si-to-participate-in-the-h-c-wainwright-27th-annual-global-investment-conference
[2] https://www.morningstar.com/news/business-wire/20250819765585/quantum-si-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference
Quantum-Si Incorporated will participate in the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025. CEO Jeff Hawkins will lead a fireside chat on September 9, 2025, and the live webcast will be available on the company's website. Quantum-Si's benchtop platform provides real-time, kinetic-based detection capabilities for protein analysis, revolutionizing protein research.
Quantum-Si Incorporated (Nasdaq: QSI) has announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference, scheduled to take place from September 8-10, 2025, at the Lotte New York Palace Hotel. The event provides an opportunity for the company to engage with investors and financial professionals.Key executives from Quantum-Si, including CEO Jeff Hawkins and Chief Financial Officer Jeff Keyes, will be present at the conference. Hawkins will lead a fireside chat on Tuesday, September 9, 2025, at 10:00 AM Eastern Time. Additionally, Keyes will be available for one-on-one meetings throughout the day on the same date. A live and archived webcast of the event will be accessible on the Quantum-Si website under the "Investors" section in the "Events & Presentations" category [1][2].
Quantum-Si is a proteomics technology company that specializes in single-molecule protein analysis. The company's benchtop platform enables real-time kinetic-based detection, allowing researchers to move beyond traditional, multistep workflows and access dynamic, functional protein insights with unparalleled resolution. This innovation simplifies and accelerates protein analysis, potentially enhancing various research and development efforts.
For more information about Quantum-Si Incorporated, visit their website at quantum-si.com or follow them on LinkedIn or X.
References:
[1] https://www.biospace.com/press-releases/quantum-si-to-participate-in-the-h-c-wainwright-27th-annual-global-investment-conference
[2] https://www.morningstar.com/news/business-wire/20250819765585/quantum-si-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet